Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FitLinxx was a prominent provider of health and fitness technology, specializing in performance tracking and wellness motivation systems. The company's core offering included a networked system for health clubs that tracked user workouts on strength and cardio equipment, providing real-time feedback and long-term data analysis. FitLinxx later expanded into the consumer and corporate wellness markets with wearable devices such as the Pebble and ActiPed, which integrated with their ActiHealth platform. The company's technology was designed to bridge the gap between physical activity and healthcare outcomes by providing verifiable activity data. Its solutions were widely adopted by organizations like the YMCA and major corporate wellness programs to drive engagement and improve member retention. In 2015, the commercial business of FitLinxx was acquired by Netpulse, a leader in branded mobile apps for the fitness industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FitLinxx.